type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• The Effect of Body Weight on Physical Activity Level, Functional Capacity, Balance, and Quality of Life in Individuals With Type 2 Diabetes Mellitus#201698ClinicalTrials.gov
• Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting#127794ClinicalTrials.gov
• The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence#146361ClinicalTrials.gov
• Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents#146424ClinicalTrials.gov
• Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin#158168ClinicalTrials.gov
• Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes#160285ClinicalTrials.gov
• BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes#162414ClinicalTrials.gov
• Glycemic Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus#172503ClinicalTrials.gov
• A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community#238252ClinicalTrials.gov
• Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin#180315ClinicalTrials.gov
• Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin#252961ClinicalTrials.gov
• Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.#261476ClinicalTrials.gov
• A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka and Vietnam#162318ClinicalTrials.gov
• Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes#18820ClinicalTrials.gov
• Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes#146427ClinicalTrials.gov
• Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin#152385ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#154871ClinicalTrials.gov
• The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy#162428ClinicalTrials.gov
• Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes#180325ClinicalTrials.gov
• Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis#201715ClinicalTrials.gov
• Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone#18801ClinicalTrials.gov
• Effect of Metformin on Exercise-induced Lipolysis#28560ClinicalTrials.gov
• Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients#67835ClinicalTrials.gov
• Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin#123391ClinicalTrials.gov
• Glycemic Evaluation of Novel Staple Foods#127755ClinicalTrials.gov
• Human Intestinal Peptides Evaluation and Research#136242ClinicalTrials.gov
• Developing Resiliency and Exercise Using AI-based Messaging#143740ClinicalTrials.gov
• Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)#146340ClinicalTrials.gov
• Use of Nutraceuticals in Clinical Practice#148604ClinicalTrials.gov
• Glucophage XR® Observational Study#175067ClinicalTrials.gov
• Arginase Inhibition in Ischemia-reperfusion Injury#180309ClinicalTrials.gov
• Phase 4 Study in the Elderly Patients With T2DM#181733ClinicalTrials.gov
• Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns#216980ClinicalTrials.gov
• Alkaline Diet for Insulin Sensitivity#238257ClinicalTrials.gov
• Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)#238310ClinicalTrials.gov
• Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive#67829ClinicalTrials.gov
• Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics#158132ClinicalTrials.gov
• A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease#181667ClinicalTrials.gov
• A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)#226225ClinicalTrials.gov
• Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects#146382ClinicalTrials.gov
• The Effect of Metformin and DPP4 Inhibitors on Cognition and Cardiovascular Protection in Type 2 Diabetic Patients#245471ClinicalTrials.gov
• Antidiabetic Effect of Olive Pomace Oil#160320ClinicalTrials.gov
• Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake#172491ClinicalTrials.gov
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)#18556ClinicalTrials.gov
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes#28552ClinicalTrials.gov
• Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin#127805ClinicalTrials.gov
• Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes#136277ClinicalTrials.gov
• The Use of Cilostazol in Patients With Diabetic Nephropathy#245429ClinicalTrials.gov
• Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes#272265ClinicalTrials.gov
• A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes#121263ClinicalTrials.gov